Lorie J. Petty, APRN, CNP

Lorie Petty practices at Katmai Oncology Group in Anchorage, Alaska.

Lorie Petty's NPI, 1952835290, was assigned on April 13, 2017. Lorie Petty graduated from Ohio State University College of Medicine in 2017. Lorie Petty holds Alaska license 209330.

Lorie Petty's primary practice is Katmai Oncology Group, at 3851 Piper St, Anchorage, AK 99508 in Anchorage Borough. The practice phone is (907) 562-0321.

Lorie Petty's primary practice is Katmai Oncology Group in Anchorage, Alaska. Lorie Petty is also affiliated with Providence Alaska Medical Center. The medical group on file is Katmai Oncology Group. Dmand AI also links Lorie Petty to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Lorie Petty practices, 6 sites in all. Vendor and product names are available with a free account.

Acute care is Lorie Petty's primary specialty in the NPI Registry, under taxonomy code 363LA2100X. Lorie Petty is licensed in Alaska.

CMS counts 67 Medicare patients who saw Lorie Petty in 2024. The largest group is 65 to 74, with 34 patients. 63% of them have cancer, and 61% have high blood pressure. Their average risk score is 1.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Lorie Petty's median patient age at 66, with 61% women.

In 2024, Lorie Petty wrote 388 Medicare Part D claims for 113 patients. 79% of them were for generic drugs.

Lorie Petty accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 9 general payments to Lorie Petty from 5 drug and device companies in 2025. Device or supply loans make up the largest share, 69% of the total. Novartis Pharmaceuticals Corporation paid the most, $341.

Lorie Petty graduated from Ohio State University College of Medicine in 2017.